|
Corporate Social Responsibility
News
10.03.2005 ET
|
CSR News from:
|
|
|
News Category:
|
|
Abbott Named to Dow Jones Sustainability Index for Leadership in Corporate Citizenship
(CSRwire) ABBOTT PARK, Ill.- Abbott today announced that it has been named to
the Dow Jones Sustainability World Index (DJSI World), as well as the new
DJSI North America and DJSI United States Indices. The addition of Abbott
to the DJSI World ranks the company among the top 10 percent of the world's
leading 2,500 companies, based on an assessment of the company's economic,
social and environmental performance. The DJSI North America and DJSI
United States indices include the top 20 percent of the 600 largest North
American companies by industry, following the same performance criteria as
the DJSI World.
"Being named to the DJSI is a direct result of the continued efforts of
Abbott employees to focus on exceptional performance and earning the trust
of those we serve," said Reeta Roy, divisional vice president, Global
Citizenship and Policy, Abbott. "As a company that has served people's
health needs for more than a century, corporate citizenship is a
fundamental driver of Abbott's business success."
Abbott is listed in the medical products group, and is the only health
care company to be added to the DJSI in 2005. Abbott also was singled out
as "best in class" in the medical products group for its performance in
numerous areas, including corporate citizenship/philanthropy,
environmental reporting, stakeholder engagement, marketing practices,
labor practices, investor relations, and risk and crisis management.
In August 2005, Abbott released its annual global citizenship report,
Living Our Values. The report details the company's progress
across a number of key areas, including efforts to integrate citizenship
throughout the company's operations, and how the company exercises its
resources, expertise and influence to address issues important to the
people it serves. Key highlights include:
Abbott's efforts to help patients access affordable health care, one
of the key issues facing the health care industry. Through various
patient assistance programs, Abbott provided more than 200,000 patients
with free and discounted medicine in the United States;
The creation of a new Global Product Protection Group to help protect
patients from the risks of counterfeit medicine;
An increase in Abbott's total social investment, including funding
and in-kind support, to more than $300 million, compared to $240 million
the previous year;
The expansion of Abbott's global ethics and compliance program, and
efforts to ensure suppliers understand Abbott standards for business
ethics; and
Five-year performance goals were established for a number of key
environmental, health and safety areas.
Abbott's full Living Our Value global citizenship report is
available online at www.abbott.com/citizenship.
Abbott is a global, broad-based health care company devoted to the
discovery, development, manufacture and marketing of pharmaceuticals and
medical products, including nutritionals, devices and diagnostics. The
company employs more than 60,000 people and markets its products in more
than 130 countries.
Abbott's news releases and other information are available on the
company's Web site at www.abbott.com.
|
|
